Colorado Cannabis Sales Hit a New Low Not Seen Since February of 2017 – The Cannibalization of the Cannabis Consumer

January 22, 2024 ·

Colorado’s medicinal marijuana industry continued to deteriorate in November 2023, with sales amounting to just $14.5 million, an 11.5% fall from the same month the previous year.

This November was the state’s cannabis industry’s fourth straight month of declining sales, indicating a concerning trend. Colorado will likely witness significant declines in marijuana sales for the second year in a row.

The “beggar they neighbor” policy of out-of-state consumers crossing over state lines to get their medical or recreational marijuana seems to be dying. As access in the legal and illegal market opens up for consumers, less consumers are headed to early-mover states to get their cannabis.  States like California, Colorado, Massachusetts are seeing sales taper off as new neighboring states like New York, Connecticut, Maine, New Mexico, and Arizona ramp up production and retail locations.

Are we finally seeing an “unofficial” effecient market as the amount of cannabis produced on the legal and illicit market is keeping up with consumer demand?  Do people now all have a “plug” they know or can get to where the product is satisfactory for the price? Let’s dig into Colorado’s sales numbers since they have a long and robust history to look at and review.

By November 2023, total cannabis sales in Colorado had surpassed $1.4 billion for the year, yet the trajectory suggests that the final 2023 figures will fall well below the impressive $1.7 billion achieved in 2022. In November, combined revenue from both recreational and medical marijuana retailers amounted to $110.5 million, marking the lowest monthly total since February 2017.

Specifically, adult-use sales, constituting approximately 87% of total sales in the state, experienced a year-over-year decline of about 16%, totalling $95.8 million. Data released by the Colorado Department of Revenue on Thursday highlighted this concerning trend.

Consequently, projections indicate that Colorado’s marijuana sales for the entire year of 2023 are expected to reach approximately $1.5 billion, reflecting a nearly 13% decrease compared to the figures from 2022. Colorado cannabis sales continued to slide in November 2023 Medical marijuana sales in November dipped to $14.5 million, down about 11.5% year-over-year.

November marked the fourth consecutive month of sales decreases in Colorado’s cannabis market.

Colorado also had their worst 4/20 cannabis sales numbers in over 5 years.

It appears the state is headed for its second straight year of significant declines in marijuana sales.

Total 2023 cannabis sales in Colorado through November eclipsed $1.4 billion but are on pace to fall well short of the state’s $1.7 billion haul in 2022. as recreational and medical marijuana retailers generated $110.5 million in revenue, the lowest monthly total since February 2017.

Adult-use sales – which accounted for roughly 87% of total sales in the state – fell to $95.8 million, down about 16% year-over-year, according to data released Thursday by the Colorado Department of Revenue.

Colorado’s 2023 marijuana sales are on pace to hit about $1.5 billion, which would be down nearly 13% from 2022.

A Closer Look at the 4-Month Slump

Colorado’s cannabis industry is facing a significant challenge as it contends with a four-month consecutive decline in sales, prompting a closer examination of the underlying factors contributing to this sustained downturn. One critical aspect to analyze is the potential economic and regulatory landscape influencing consumer behavior. Changes in laws, taxation policies, or broader economic conditions may be impacting the purchasing decisions of both medical and recreational marijuana consumers. Additionally, a detailed exploration of market-specific dynamics, such as the emergence of new competitors or shifts in consumer preferences, can offer valuable insights into the reasons behind this prolonged slump.

The persistent decline also raises questions about the impact on businesses operating within the cannabis sector and the overall employment landscape. As sales continue to slide, businesses may be forced to make difficult decisions regarding staffing levels and operational strategies. Investigating how companies adapt to these challenging circumstances provides a nuanced understanding of the industry’s resilience and adaptability. Furthermore, examining the response from regulatory bodies and the government is crucial, as policies and support measures may play a pivotal role in mitigating the adverse effects of the sales downturn, fostering an environment conducive to recovery and growth.

Amidst the ongoing slump, an exploration of shifting consumer behaviors becomes imperative to comprehend the broader market dynamics. Whether consumers are altering their preferences, exploring alternative products, or reacting to external economic uncertainties, understanding these behavioral shifts is vital for predicting future trends. Unraveling the complexities of this four-month decline involves a comprehensive analysis of economic, regulatory, and consumer-related factors, providing stakeholders with actionable insights to navigate the current challenges and position themselves strategically for the future.

Assessing the Implications for the Cannabis Market

The examination of Colorado’s cannabis sales in 2023 in comparison to preceding years highlights a challenging landscape within the state’s marijuana market. The significant disparity between the current revenue figures and the remarkable $1.7 billion achieved in 2022 underscores the gravity of the ongoing decline. A thorough analysis of this trajectory is imperative to discern patterns, anomalies, and underlying factors contributing to the market’s downturn, providing crucial context for evaluating the industry’s overall health and adaptability.

Assessing the implications of the sales decline extends beyond immediate financial concerns, delving into the potential long-term effects on Colorado’s marijuana market. This sustained decrease raises questions about its impact on investor confidence, business strategies, and the broader economic contributions of the cannabis sector to the state. Stakeholders, including policymakers, businesses, and investors, need to carefully consider these long-term implications to make informed decisions about their continued involvement and support for the industry.

Exploring how businesses within the cannabis market are adapting to the challenging conditions is essential in understanding the industry’s resilience. An analysis of potential shifts in focus, such as diversification of product offerings or exploration of new markets, provides insights into adaptive strategies employed by businesses. Understanding these responses contributes to a broader comprehension of the industry’s capacity to navigate evolving market dynamics, showcasing the creativity and flexibility of businesses within Colorado’s cannabis sector.

Examining the 16% Drop in Adult-Use Sales

In November 2023, Colorado’s recreational cannabis sector, representing 87% of total sales, experienced a substantial setback with a pronounced 16% year-over-year decline in sales, totalling $95.8 million. The implications of this downturn, highlighted by data from the Colorado Department of Revenue, necessitate a thorough investigation into the factors influencing this specific market segment and the potential ramifications for the broader cannabis industry.

The sharp decline in adult-use sales directly impacts the overall revenue landscape within Colorado’s cannabis market, accentuating the sector’s significance. The reasons behind the 16% drop involve a nuanced exploration of consumer preferences and regulatory dynamics. Changes in what consumers seek in recreational cannabis products, coupled with shifts in regulatory frameworks, may be contributing factors. Understanding these elements not only offers insights into the present market dynamics but also enables anticipation of potential shifts in consumer behavior that could shape the industry’s trajectory in the future. Amidst these challenges, assessing strategies for recovery becomes essential, as businesses within the recreational cannabis sector may need to reassess marketing approaches, diversify product offerings, or explore innovative avenues to revive consumer interest. This exploration not only sheds light on the resilience of businesses operating in the recreational segment but also underscores their adaptive capacity to navigate and recover from evolving market conditions.

Bottom Line

Colorado’s cannabis industry witnessed a concerning downturn in November 2023, with medicinal marijuana sales hitting a nearly 7-year low at just $14.5 million, marking an 11.5% decline from the previous year. The four-month consecutive slump in sales raises alarm, prompting an in-depth examination of economic, regulatory, and consumer factors contributing to the decline. Despite total cannabis sales surpassing $1.4 billion by November, projections suggest a significant drop compared to the impressive $1.7 billion achieved in 2022. This challenging landscape prompts a closer look at the long-term implications on investor confidence, business strategies, and the industry’s economic contributions, emphasizing the need for adaptive measures and strategic recovery strategies within the cannabis sector. (Full Story)

In category:Business
Next Post

Green Rush Leaves ‘Ghost Town’ of Grow Facilities in Ordway, Colorado

Is a town in Colorado the first to become a cannabis ghost town? Westword’s Thomas Mitchell reported that the green rush of cannabis business licenses in Colorado left the town of Ordway a “ghost town,” filled with vacant growing operations. Hasn’t…
Previous Post

HR Trends and Talent Insights for the Year Ahead

The human resources trends set to dominate 2024 are certain to disrupt the industry, mostly for the better. This year will be prosperous as multistate brands continue to expand into other states, but there will be challenges. One major inflection point will…
Random Post

Gov. Newsom Signs Bill Allowing MDMA, Psilocybin Prescriptions If/When Feds Reschedule

Governor Gavin Newsom has signed a bill into law which would allow California doctors to immediately begin writing prescriptions for MDMA and psilocybin medications should the federal government choose to reschedule them. Gov. Newsom signed AB 1021 on Saturday in an effort…
Random Post

Ukraine MMJ Bill Unblocked After Repeal Effort Fails To Receive Needed Votes

After hitting a brief snag late last year, a bill approved by Ukraine’s unicameral legislature in December to legalize medical cannabis in the country appears to be back on track. The delay occurred when the opposing Batkivshchyna (Fatherland) party and…
Random Post

Hawaii Senate Votes to Legalize Cannabis

The Hawaii Senate voted 22-3 in favor of an adult-use cannabis legalization proposal yesterday; the measure moves next to the House. The Hawaii Senate on Tuesday overwhelmingly passed an adult-use legalization bill by a 22-3 margin. The measure still requires approval in…
Random Post

Wyoming Draft Bill Seeks to Outlaw Hemp-Derived THC Products

A draft bill in Wyoming aims to ban hemp-derived THC products and any other hemp products meant for human consumption, Cowboy State Daily reports. Under the proposal, “hemp with any detectable amount of natural or synthetic tetrahydrocannabinol (THC), as well as any production of…